Oncology
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 37–48 of 246 articles
FDA Approvals in Oncology: January-March 2026
China Approves HERNEXEOS for Lung Cancer Treatment
AI Breast Cancer Risk Prediction Tool Gains FDA Approval
FDA Approves Durvalumab and BCG for High-Risk NMIBC
US FDA Extends Decision Date for Camizestrant Filing
ASCO 2026: What to Expect from the Upcoming Event
Lifesaving Upgrades: 40 Years of FDA Oncology Approvals
FDA Guidelines Enhance Generic Bioequivalence in Oncology Drugs
Mirum Maps FDA Path After Anti-Itch Candidate Scores Phase 2 Win
FDA vs EMA: The Camizestrant Controversy
FDA Grants Early Access to Promising Drug for Pancreatic Cancer
FDA Approves Expanded Access for Daraxonrasib in Pancreatic Cancer